Valeo Pharma Inc.

VPHIF · OTC
Analyze with AI
10/31/2023
10/31/2022
10/31/2021
10/31/2020
Operating Activities
Net Income-$28-$26-$14-$5
Dep. & Amort.$3$1$1$0
Deferred Tax$0-$1$1$0
Stock-Based Comp.$1$1$1$0
Change in WC$4-$11-$1-$2
Other Non-Cash$4$8$1$0
Operating Cash Flow-$16-$29-$12-$5
Investing Activities
PP&E Inv.-$0-$7-$3-$1
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$5$0$0$0
Investing Cash Flow-$6-$7-$3-$1
Financing Activities
Debt Repay.$3$20$4$2
Stock Issued$4$0$12$7
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0$35$0$0
Financing Cash Flow$6$55$15$9
Forex Effect$0$1-$0-$0
Net Chg. in Cash-$15$20-$1$3
Supplemental Information
Beg. Cash$23$2$3$0
End Cash$8$23$2$3
Free Cash Flow-$21-$35-$16-$7